Ontology highlight
ABSTRACT: Background
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, characterized by aggressive growth and a dismal prognosis. Interleukin-33 (IL-33) and its receptor ST2 have emerged as regulators of glioma growth, but their exact function in tumorigenesis has not been deciphered. Indeed, previous studies on IL-33 in cancer have yielded somewhat opposing results as to whether it is pro- or anti-tumorigenic.Methods
IL-33 expression was assessed in a GBM tissue microarray and public databases. As in vivo models we used orthotopic xenografts of patient-derived GBM cells, and syngenic models with grafted mouse glioma cells.Results
We analyzed the role of IL-33 and its receptor ST2 in nonmalignant cells of the glioma microenvironment and found that
SUBMITTER: Wicher G
PROVIDER: S-EPMC11808570 | biostudies-literature | 2025 Jan-Dec
REPOSITORIES: biostudies-literature